Seroprevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among hemodialysis patients in a Tertiary Care Teaching Hospital in a developing country
Conclusion: Prevalence of transfusion-transmissible viral infections was higher among hemodialysis patients, especially HCV infection which was an alarming situation and therefore strict adherence to infection control strategies, barrier precautions, and preventive measures, including routine hepatitis B vaccination and regular virological follow-up were recommended along with regular education and training programs of technical and nursing personnel's involved with dialysis patients.
Publication date: Available online 20 September 2020Source: Materials Today: ProceedingsAuthor(s): Mohd Javeed Mehdi, N Srinivasrao, A Sireesha
Publication date: Available online 20 September 2020Source: Materials Today: ProceedingsAuthor(s): Vani Ramesh, Ramanathan
Presentation of CF, airway clearance regimens, diabetes in CF, and other highlights from the cystic fibrosis episode of The Cribsiders podcast.Medscape Pediatrics
CONCLUSIONS: Glecaprevir/pibrentasvir was effective and well tolerated in treatment-naïve Brazilian patients with hepatitis C infection without cirrhosis and with compensated cirrhosis. TRIAL REGISTRATION: ClinicalTrials.gov NCT03219216. PMID: 32949786 [PubMed - as supplied by publisher]
CONCLUSION: Type 4 collagen could predict the presence of significant and advanced fibrosis in NAFLD patients and it would be a useful tool in routine clinical practice. PMID: 32949785 [PubMed - as supplied by publisher]
Publication date: Available online 21 September 2020Source: Biosensors and BioelectronicsAuthor(s): Sujasha Gupta, Subhadip Ghatak, Travis Hery, Savita Khanna, Mohamed El-Masry, Vishnu Baba Sundaresan, Chandan K. Sen
Patrick Vallance and Chris Whitty ’s briefing predicted an autumn of rising deaths and difficult lockdown choicesCoronavirus – latest updatesSee all our coronavirus coverageThe government ’s most senior scientists, England’s chief medical officer, Chris Whitty, and the chief scientific adviser, Sir Patrick Vallance, have given a televised briefing about the recent increases in coronavirus cases, and what to expect – unusually, doing so without a politician there as well. Here i s what we learned.Continue reading...
Publication date: October 2020Source: American Journal of Kidney Diseases, Volume 76, Issue 4Author(s): Arvind Kumar Garg, Priyanka Parajuli, Chaitanya Kumar Mamillapalli
Publication date: October 2020Source: American Journal of Kidney Diseases, Volume 76, Issue 4Author(s): Sarthak Virmani, William S. Asch
Publication date: Available online 21 September 2020Source: American Journal of Kidney DiseasesAuthor(s): Ronald L. Pisoni, Lindsay Zepel, Junhui Zhao, Steven Burke, Charmaine E. Lok, Kenneth J. Woodside, Haimanot Wasse, Hideki Kawanishi, Douglas Schaubel, Jarcy Zee, Bruce M. Robinson
More News: AIDS Vaccine | Diabetes | Diabetes Mellitus | Dialysis | Education | Endocrinology | Epidemiology | Hemodialysis | Hepatitis | Hepatitis B | Hepatitis C | Hepatitis Vaccine | HIV AIDS | Hypertension | India Health | Infectious Diseases | Nephritis | Nurses | Nursing | Sexual Abuse | STDs | Study | Substance Abuse | Teaching | Teaching Hospitals | Training | Transplants | Universities & Medical Training | Urology & Nephrology | Vaccines | Virology